Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Here's Why Alder Biopharmaceuticals Inc Stock Is Bouncing Back


Investors in Alder Biopharmaceuticals (NASDAQ: ALDR) are having another wild day. Shares of the clinical-stage biopharma rose as much as 15.5% on Thursday after the company released the pricing details of its just announced common-stock offering. As of 12:43 p.m. EDT, the stock was up 13.7%.

Alder stated that it is selling 15 million shares of its common stock for $10 each. In addition, the underwriters of the deal have been granted a 30-day option to purchase up to 2.25 million additional shares at the offering price. The deal is expected to close early next week and could add up to $172.5 million to the company's bank account before subtracting fees.

Image source: Getty Images.

Continue reading


Source: Fool.com

Eli Lilly Corp. Stock

€751.00
-0.910%
The price for the Eli Lilly Corp. stock decreased slightly today. Compared to yesterday there is a change of -€6.900 (-0.910%).
With 62 Buy predictions and 1 Sell predictions Eli Lilly Corp. is one of the favorites of our community.
As a result the target price of 824 € shows a slightly positive potential of 9.72% compared to the current price of 751.0 € for Eli Lilly Corp..
Like: 0
LLY
Share

Comments